Evergreen Theragnostics News and Resources

CDMO News

Orbit Discovery and Evergreen Theragnostics Expand Peptide Collaboration for Radiopharmaceuticals

Orbit Discovery, a leader in peptide discovery services, and Evergreen Theragnostics, a radiopharmaceutical firm, have announced the extension of their partnership to develop novel targeting peptides. Building on their initial agreement from April 2023, the collaboration focuses on identifying high-affinity

4 December 2024

CDMO News

Evergreen Theragnostics Raises $26M, Boosting Radiopharma and CDMO Capabilities

Evergreen Theragnostics, US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today the successful completion of a $26M capital raise. This funding was supported by both existing shareholders and new institutional investors, Petrichor and LIFTT. The raised capital will be

17 April 2024

Welcome to PharmaSource

Join the global community of outsourcing & procurement professionals from the world’s leading pharma and biotechs:

Stay ahead of trends and best practices

Exclusive downloads and podcasts

Get invites to special events and meetups

Sign up for your free membership

Evergreen Theragnostics News and Resources

Orbit Discovery and Evergreen Theragnostics Expand Peptide Collaboration for Radiopharmaceuticals

Evergreen Theragnostics Raises $26M, Boosting Radiopharma and CDMO Capabilities

Welcome to PharmaSource

Follow us

Top Links

Get in touch

Who do you rate?

Recommend a Supplier